Video

Stress, Resilience, and Digital Health Research in the Era of COVID-19

Mount Sinai has been on the forefront of trauma, stress, depression, and resilience research for decades. This virtual symposium covers the latest: what we know, and what we are learning that can equip us in addressing the pandemic’s psychological ...

Video

From Party to Prescription: How Psychedelics Are Changing Traditional Psychiatry

Listen as Mount Sinai neuroscientists discuss ketamine, cannabis, and ecstasy as potential treatments for treatment-resistant depression, opioid addiction, and post-traumatic stress disorder

Video

New Frontiers for Depression: Deep Brain Stimulation, Esketamine, and the Immune System

“In five years, we expect to have a range of new treatments available targeting people with different forms of depression that work effectively, specifically for them.” –Eric Nestler, MD, PhD